SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil-Reference-Cited by-同舟云学术

SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil

Published:2022-04 Issue:4 Volume:28 Page:734-742
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Chaves Daniel Gonçalves,Takahashi Ricardo Hiroshi Caldeira,Campelo Felipe,da Silva Malta Maria Clara Fernandes,de Oliveira Isabelle Rocha,Barbosa-Stancioli Edel Figueiredo,Ribeiro Maísa Aparecida,Martins Marina Lobato

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference31 articles.

1. World Health Organization. WHO coronavirus (COVID-19) dashboard [cited 2021 Sep 15]. https://covid19.who.int

2. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study.;Huang;J Infect,2020

3. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.;Lai;J Microbiol Immunol Infect,2020

4. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.;Buitrago-Garcia;PLoS Med,2020

5. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.;Zhou;J Med Virol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors;Frontiers in Cellular and Infection Microbiology;2024-06-21

2. Differences in SARS-CoV-2 antibodies depending on age, blood group, and sex in a Swedish blood donor cohort;Scandinavian Journal of Clinical and Laboratory Investigation;2024-06-21

3. Utility of COVID-19 Seropositive Plasma as Convalescent Plasma: An Immune and Neutralization Antibody Seroprevalence Analysis in Blood Donors for Future Potential Pandemic Readiness;Cureus;2024-03-28

4. Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis;Advances in Virology;2022-07-21

5. COVID-19 in Blood Donors at Laquintinie Hospital in Douala during the Third Wave: A Cross Sectional Study;Open Journal of Epidemiology;2022